Walter Gilbert

Wally Gilbert is a leading molecular biologist, formerly a member of the Harvard faculty, and a founder of Biogen, serving as its Chairman and CEO from 1981 until 1985. After returning to Harvard University, he later became the Carl M. Loeb University Professor. He was an advisor to BVI at its inception and became a partner in 2003. In 1975, Wally developed a method of rapid DNA sequencing for which he received the Nobel Prize in Chemistry in 1980. He is a co-founder and Vice-Chairman of Myriad Genetics Inc. (NASDAQ: MYGN) and a co-founder and Chairman of Paratek Pharmaceuticals Inc. He was a co-founder and Director of Memory Pharmaceuticals Inc. (acquired by Roche). He also served as a Director of Transkaryotic Therapies (now Shire Human Genetic Therapies). While a member of the BioVentures Investors Fund I Board of Advisors, he co-founded Pintex Pharmaceuticals Inc., a Fund I portfolio company, and served as Chairman of the Board of Directors. As a BioVentures Investors Managing Director he served on the Board of Directors of Hospital Care Online, Pintex, ActivBiotics, Verax, Cylene, and Hydra Biosciences (obs). Wally earned an A.B. in Chemistry and Physics from Harvard College, an M.A. in Physics from Harvard University, and a Doctor of Philosophy in Mathematics from Cambridge University. He has several honorary doctorates